EUVIMEDEUVIMED entdecken
Open Access

Adipokine Nesfatin‐1 Mediates Endothelial Dysfunction by Suppressing MEF2B / BMPR1A During Pulmonary Vascular Remodeling

Jie Liu iD, Yu Guo iD, Jing Huang, Zhenqiang Gao iD, Muzhi Zhang iD, Yufeng Jia, Huanyu Long iD, Xin Xue, Hanxiao Zhang, Wenhua Shi iD, Cong Li, Yonghong Zhang iD und 3 weitere

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.047528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Jie Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences Capital Medical University Beijing China. Hauptthemen laut MEDLINE: Vascular Remodeling, Hypertension, Pulmonary, Nucleobindins, MEF2 Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

How perivascular adipose tissue (PVAT) controls vascular remodeling and perivascular inflammation during pulmonary hypertension progresses remains unknown.

Methods

Western blotting, ELISA, immunohistochemistry, and immunofluorescence were used to measure proteins expression. Sugen 5416 combined with hypoxia (SuHx) mouse models were established in C57BL/6 mice, and treated with CL‐316243. Adeno‐associated virus vector delivery was used to specifically delete nesfatin‐1 in adipocytes of lung in mice. Transthoracic echocardiography was performed to evaluate the function of right ventricle. Assays for cell angiogenesis and adhesion were used to analyze endothelial cell function. A noncontact transwell coculture model was used to evaluate the interaction between different types of cells.

Results

PVAT dysfunction participates in SuHx‐induced pulmonary vascular remodeling, PVAT exhibits features of white adipose tissue and the adipocytokine nesfatin‐1 is the key mediator. Browning of white adipose tissue via CL‐316243 treatment attenuates pulmonary hypertension phenotype in a SuHx–pulmonary hypertension mouse model. Specific deletion of nesfatin‐1 in adipocytes of lung attenuates SuHx‐induced pulmonary vascular remodeling. Nesfatin‐1 secretion is induced by IL‐17/Th17 via PI3K/AKT/mTOR pathway. In vitro, nesfatin‐1 promotes angiogenesis, adhesion, and apoptosis of endothelial cells. Coculture with 3T3‐L1 adipocytes promotes endothelial dysfunction mediated by nesfatin‐1. Mechanistic research shows that nesfatin‐1 mediates endothelial dysfunction by downregulating BMPR1A expression via MEF2B at the transcriptional and posttranslational levels.

Conclusions

PVAT dysfunction participates in pulmonary vascular remodeling through nesfatin‐1–mediated endothelial dysfunction, suggesting that PVAT and nesfatin‐1 may constitute novel therapeutic targets for pulmonary hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular RemodelingHypertension, PulmonaryNucleobindinsMEF2 Transcription FactorsNerve Tissue ProteinsDNA-Binding ProteinsPulmonary ArteryCalcium-Binding ProteinsEndothelium, VascularAnimalsMice, Inbred C57BLDisease Models, AnimalSignal TransductionMaleEndothelial CellsMiceCoculture Techniques

Stichwörter der Autor:innen

BMPR1APVATnesfatin‐1pulmonary vascular remodeling

Substanzen

NucleobindinsMEF2 Transcription FactorsNerve Tissue ProteinsDNA-Binding ProteinsNucb2 protein, mouseNucb1 protein, mouseCalcium-Binding Proteins

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences Capital Medical University Beijing China.
  • Department of Rheumatism and Immunology The First Affiliated Hospital of Xi'an Jiaotong University Xi'an China.
  • Department of Pulmonary and Critical Care Medicine Peking University Third Hospital Beijing China.
  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital) Shaanxi China.
  • Department of Cardiovascular Surgery, Beijing Chaoyang Hospital Capital Medical University Beijing China.

ORCID-Profile: Jie Liu, Yu Guo, Zhenqiang Gao, Muzhi Zhang, Huanyu Long, Wenhua Shi, Yonghong Zhang, Aijun Liu, Lei Wang

Zitieren

APA

Liu, J., Guo, Y., Huang, J., Gao, Z., Zhang, M., Jia, Y., Long, H., Xue, X., Zhang, H., Shi, W., Li, C., Zhang, Y., Yang, S., Liu, A., & Wang, L. (2026). Adipokine Nesfatin‐1 Mediates Endothelial Dysfunction by Suppressing MEF2B / BMPR1A During Pulmonary Vascular Remodeling. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047528

Vancouver

Liu J, Guo Y, Huang J, Gao Z, Zhang M, Jia Y, et al. Adipokine Nesfatin‐1 Mediates Endothelial Dysfunction by Suppressing MEF2B / BMPR1A During Pulmonary Vascular Remodeling. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.047528

BibTeX
@article{Liu2026,
  author = {Liu, Jie and Guo, Yu and Huang, Jing and Gao, Zhenqiang and Zhang, Muzhi and Jia, Yufeng and Long, Huanyu and Xue, Xin and Zhang, Hanxiao and Shi, Wenhua and Li, Cong and Zhang, Yonghong and Yang, Shuanying and Liu, Aijun and Wang, Lei},
  title = {Adipokine Nesfatin‐1 Mediates Endothelial Dysfunction by Suppressing MEF2B / BMPR1A During Pulmonary Vascular Remodeling},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.047528}
}
Kostenlos starten →